Karolinska Development AB (publ)

OM:KDEV Stock Report

Market Cap: SEK 258.0m

Karolinska Development Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of KDEV?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders983,2760.364%
Institutions28,685,78710.6%
Private Companies28,890,32310.7%
General Public82,537,54230.6%
Public Companies128,736,38147.7%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 24 shareholders own 69.41% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
47.7%
Sino Biopharmaceutical Limited
128,736,381SEK 123.1m0%no data
8.66%
Worldwide International Investments Limited
23,379,244SEK 22.4m-7.87%no data
3.24%
Swedbank Robur Fonder AB
8,750,000SEK 8.4m0%no data
2.13%
Avanza Fonder AB
5,744,757SEK 5.5m22.1%no data
1.94%
Styviken Invest
5,236,206SEK 5.0m0%no data
1.6%
Stiftelsen för Främjande och Utveckling av Medicinsk Forskning vid Karolinska Institutet
4,311,079SEK 4.1m0%no data
0.92%
Coastal Investment Management, L.P.
2,470,541SEK 2.4m0%100.0%
0.63%
Nordnet Pensionsförsäkring Ab, Asset Management Arm
1,697,059SEK 1.6m21.2%0.03%
0.5%
Handelsbanken Asset Management
1,348,363SEK 1.3m-3.8%no data
0.44%
Adis Holding AB
1,200,000SEK 1.1m0%no data
0.43%
Skandia Fonder AB
1,158,749SEK 1.1m0%no data
0.39%
SEB Investment Management AB
1,062,168SEK 1.0m0%no data
0.36%
FCG Fonder AB
968,458SEK 925.8k0%0.01%
0.15%
Johan Dighed
400,192SEK 382.6k0%no data
0.092%
Storebrand Fonder AB,
249,486SEK 238.5k0%no data
0.078%
Viktor Drvota
209,996SEK 200.7k0%no data
0.059%
Per Aniansson
160,006SEK 153.0k0%no data
0.024%
Ben Toogood
64,001SEK 61.2k0%no data
0.013%
Elisabet Gimbringer
36,000SEK 34.4k0%no data
0.013%
Hans Toll
35,000SEK 33.5k0%no data
0.012%
Eva Montgomerie
33,071SEK 31.6k0%no data
0.0093%
Yan Cheng
25,004SEK 23.9k0%no data
0.0037%
Linda Spahiu
10,003SEK 9.6k0%no data
0.0037%
Mikaela Sörman
10,003SEK 9.6k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/09 22:26
End of Day Share Price 2025/05/09 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Karolinska Development AB (publ) is covered by 7 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Johan LöchenABG Sundal Collier Sponsored
Klas PalinCarnegie Commissioned Research
Espen JørgensenDNB Markets